The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

This study describes a validation of the BD Onclarity HPV (Onclarity) assay using the international guidelines for HPV test requirements for cervical cancer screening of women 30 years old and older using Danish SurePath screening samples. The clinical specificity (0.90, 95% confidence interval [CI]...

Descripción completa

Detalles Bibliográficos
Autores principales: Ejegod, Ditte, Bottari, Fabio, Pedersen, Helle, Sandri, Maria Teresa, Bonde, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005508/
https://www.ncbi.nlm.nih.gov/pubmed/27307461
http://dx.doi.org/10.1128/JCM.00508-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005508/
https://www.ncbi.nlm.nih.gov/pubmed/27307461
http://dx.doi.org/10.1128/JCM.00508-16

Ejemplares similares